hCG Tumor Marker

Overview

  • EPIC Code:
  • LAB752
  • Soft Test Code:
  • HCGTM
  • Send Out Test Code:
  • BHCG (61718)
Alternate Names
  • CG (Chorionic Gonadotropin)
  • Chorionic Gonad, Beta-Subunit QN, Serum
  • Chorionic Gonadotropin Subunit HCG
  • Chorionic Gonadotropin, Beta-Subunit (Quantitative
  • Gonadotropins, Chorionic
  • HCG (Human Chorionic Gonadotropin) (Tumor Marker)
  • Hcg Quantitative
  • hCG, Beta Subunit (Chorionic Gonad)
  • hCG, Total QN
  • HCG,B-SUBUNIT(S)
  • Human Chorionic Gonadotropins
  • Soft-HCGB
Clinical Significance

Monitoring patients for retained products of conception
Diagnosis of gestational trophoblastic disease (GTD), testicular tumors, ovarian germ cell tumors, teratomas, and, rarely, other human chorionic gonadotropin (hCG)-secreting tumors
Serial measurement of hCG following treatment to:
-Monitor therapeutic response in GTD or in hCG-secreting tumors
-Detect persistent or recurrent GTD or hCG-secreting tumors


Specimen Collection & Preparation

Specimen Requirements

1.0 mL Serum from a Red Top Tube in a Plastic Vial


Transport And Storage

7 days Refrigerated


Collection Instructions

 


Minimum Volume

0.3 mL


Neonatal Volume

Clinical Interpretation

Reference Range:

Refer to interpretive report


Test Comments:

All values > 4 and < 10 will have the following message applied, if the patient is female or no gender is provided: Values less than 10 are considered normal for postmenopausal females. Values from different assay methods may vary. The use of  this assay to monitor or to diagnose patients with cancer or any condition unrelated to pregnancy has not been approved by the FDA or the manufacturer of this assay.


Methodology:
  • Immunoassay (IA)
Clinical Significance

Monitoring patients for retained products of conception
Diagnosis of gestational trophoblastic disease (GTD), testicular tumors, ovarian germ cell tumors, teratomas, and, rarely, other human chorionic gonadotropin (hCG)-secreting tumors
Serial measurement of hCG following treatment to:
-Monitor therapeutic response in GTD or in hCG-secreting tumors
-Detect persistent or recurrent GTD or hCG-secreting tumors


Production Schedule

Sites Performed
  • Mayo Laboratory
Days Performed
Sunday
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Departments
  • Sendouts - Clinical
Turn Around Time

3 to 5 days


Coding & Compliance

CDM

00910074


CPT Coding

84702


Medical Necessity May Apply